Membrane-associated guanylate kinases (MAGUKs) are the major family of scaffolding proteins at the postsynaptic density. The PSD-MAGUK subfamily, which includes PSD-95, PSD-93, SAP97, and SAP102, is well accepted to be primarily involved in the synaptic anchoring of numerous proteins, including N-methyl-D-aspartate receptors (NMDARs). Notably, the synaptic targeting of NMDARs depends on the binding of the PDZ ligand on the GluN2B subunit to MAGUK PDZ domains, as disruption of this interaction dramatically decreases NMDAR surface and synaptic expression. We recently reported a secondary interaction between SAP102 and GluN2B, in addition to the PDZ interaction. Here, we identify two critical residues on GluN2B responsible for the non-PDZ binding to SAP102. Strikingly, either mutation of these critical residues or knockdown of endogenous SAP102 can rescue the defective surface expression and synaptic localization of PDZ binding-deficient GluN2B. These data reveal an unexpected, nonscaffolding role for SAP102 in the synaptic clearance of GluN2B-containing NMDARs.
INTRODUCTION
NMDARs are ionotropic glutamate receptors that play important roles in excitatory neurotransmission, synaptic plasticity, and neuronal development (Lau and Zukin, 2007) . Precise regulation of NMDAR trafficking and synaptic localization is essential for these functions. NMDARs are localized at the postsynaptic membrane, and are stabilized through interactions with membrane-associated guanylate kinases (MAGUKs) . SAP97 , and SAP102 are collectively known as PSD-MAGUKs and possess three PDZ domains, a Src homology 3 (SH3) domain and an inactive guanylate kinase (GK) domain (Elias and Nicoll, 2007) . The PDZ domains bind to the C termini of NMDARs, whereas the SH3 and GK domains interact with cytoskeletal proteins and intracellular signaling complexes. Although PSD-MAGUKs share a common modular structure, each family member possesses a distinct N-terminal domain. The N termini of PSD-95, PSD-93, and SAP97 contain either a pair of palmitoylated cysteines that stabilize them at synapses or an L27 domain capable of multimerization (Schlü ter et al., 2006) . The N terminus of SAP102, however, is not palmitoylated and does not have an L27 domain and thus has an unknown function. Recently, we found that the N terminus of SAP102 contains a GluN2B-specific NMDAR binding site .
Functional NMDARs are heterotetramers assembled with two GluN1 subunits and two GluN2 (GluN2A-GluN2D) and/or GluN3 (GluN3A-GluN3B) subunits. The GluN2 subunits have distinct expression patterns with GluN2A and GluN2B being the major GluN2 subunits in the forebrain. The GluN2 content of NMDARs determines their channel properties, as well as their coupling to distinct intracellular signaling cascades (Cull-Candy and Leszkiewicz, 2004) . During development, GluN2B is predominantly expressed in immature neurons and the expression of GluN2A gradually increases, leading to a synaptic switch from GluN2B-to primarily GluN2A-containing NMDARs. In mature neurons, GluN2A-containing NMDARs are primarily localized at synapses, whereas GluN2B-containing receptors are still present at synapses, but also enriched at extrasynaptic sites (Li et al., 2002; Stocca and Vicini, 1998; Tovar and Westbrook, 1999) . In addition, GluN2B-containing NMDARs undergo more robust endocytosis (Lavezzari et al., 2004; Roche et al., 2001 ) and have higher surface mobility than GluN2A-containing receptors . Biochemical studies have shown that GluN2A preferentially binds to PSD-95 and GluN2B preferentially binds to SAP102 (Sans et al., 2000; van Zundert et al., 2004; although, see Al-Hallaq et al., 2007) , and it has been proposed that PSD-95 and SAP102 play a role in the subunit-specific regulation of receptor trafficking and localization (van Zundert et al., 2004) . Interestingly, SAP102 is not palmitoylated and is highly mobile at the postsynaptic density, similar to GluN2B (Zheng et al., 2010 ).
GluN2A and GluN2B share an identical PDZ ligand. However, we have recently identified a secondary non-PDZ GluN2B binding site in the N-terminal domain of SAP102, which might allow for preferential binding of SAP102 and GluN2B . In the present study, we investigated the role of the PDZ-independent interaction of GluN2B with SAP102 in NMDAR trafficking. We identify two amino acids within the GluN2B C terminus (D1391; D1392) that are critical for binding to the SAP102 N-terminal domain.
Mutating the PDZ ligand on GluN2B profoundly reduces surface expression of NMDARs (Chung et al., 2004; Prybylowski et al., 2005) and the activity-dependent phosphorylation of GluN2B within the PDZ ligand by casein kinase 2 (CK2) drives the removal of GluN2B from the synapse (Sanz-Clemente et al., 2010) . We now show that disruption of the secondary SAP102 binding site on GluN2B unexpectedly and dramatically rescues the surface and synaptic expression of PDZ bindingdeficient GluN2B. Furthermore, RNAi knockdown of SAP102 also rescued the surface and synaptic expression defect of the GluN2B PDZ ligand mutant. Together, our findings reveal an unexpected role for the PDZ-independent interaction between SAP102 and GluN2B in mediating the synaptic clearance of GluN2B-containing NMDARs.
RESULTS
To identify the PDZ-independent SAP102 binding site in GluN2B, we analyzed a series of GluN2B truncations using a yeast twohybrid assay. We found a region of the GluN2B C terminus (amino acids 1353-1441) that is required for the non-PDZ interaction ( Figure 1A ), but attempts to delineate this region further were limited by self-activation of the yeast two-hybrid system. We next generated GluN2A-GluN2B chimeras and found that the GluN2A (1304-1400)-GluN2B (1422-1482) chimera (Figure 1A) interacted with the SAP102 N-terminal domain (Figure 1A) , suggesting a short region in GluN2B (1422-1441) is critical for the interaction. Surprisingly, however, this region alone did not interact with the N terminus of SAP102. We therefore postulated that the adjacent region of GluN2B (1353-1400) is a key molecular determinant for binding to the SAP102 N-terminal domain, whereas 1422-1441 is simply permissive but cannot interact independently. Consistently, we found that GluN2B (1-1441) and GluN2B (1-1400), but not GluN2B (1-1353), coimmunoprecipitated with SAP102 ( Figures 1A and S1 ). Based on the chimeras, we hypothesized that the critical residues in the GluN2B (1353-1400) segment must be conserved between GluN2A and GluN2B, but that these residues only interact with the SAP102 N terminus when the GluN2B (1422-1441) region is also present. To test this possibility, we made specific amino acid substitutions within GluN2B (1353-1400), which are identical in the analogous region of GluN2A (1304-1400) ( Figure 1B ). We first targeted several charged residues and found that the GluN2B D1391K and D1392K mutations ( Figure 1B ), but not D1378K ( Figure S1 ), disrupted the PDZ-independent binding to SAP102. Moreover, the GluN2B D1391K and D1392K (GluN2B DD-KK) double mutant further reduced the interaction (Figure 1B) . We also examined the PDZ-independent interaction using a coimmunoprecipitation assay in HEK293 cells expressing GluN1, GluN2B DD-KK or GluN2B DD-KK S1480E, and SAP102. We found that GluN2B DD-KK S1480E showed a 54% reduction in SAP102 binding compared with GluN2B S1480E (Figure 1B) , demonstrating that GluN2B D1391 and D1392 are involved in the interaction of GluN2B with the SAP102 N terminus.
Phosphorylation of Ser1480 within the GluN2B PDZ-binding motif by CK2 disrupts the interaction of GluN2B with PSD-95 and SAP102 and decreases surface expression of GluN2B (Chung et al., 2004) . However, the role of the PDZ-independent interaction of GluN2B with SAP102 in NMDAR trafficking is not known. Therefore, we used the GluN2B DD-KK double mutant to study whether the PDZ-independent interaction with SAP102 regulates surface expression of GluN2B. We expressed GFP-GluN2B WT or GFP-GluN2B DD-KK in hippocampal neurons and visualized surface-expressed receptors with an anti-GFP antibody. Surface expression of GFP-GluN2B DD-KK was similar to that of GFP-GluN2B WT (Figure 2 ). We then investigated whether disruption of both the PDZ and PDZindependent interactions could affect NMDAR trafficking. To this end, we mutated Ser1480 of GluN2B to glutamate to mimic phosphorylation of Ser1480, which disrupts the PDZ binding of GluN2B and examined the surface expression of GFP-GluN2B S1480E and a combined GFP-GluN2B DD-KK S1480E mutant. Consistent with previous reports (Chung et al., 2004) , surface expression of GFP-GluN2B S1480E was dramatically reduced compared to WT (Figure 2 ). Strikingly, surface expression was recovered with GFP-GluN2B DD-KK S1480E and was similar to wild-type GluN2B (Figure 2 ), demonstrating that DD-KK mutations, which disrupt binding to the SAP102 N terminus, rescue the surface expression defect of GFP-GluN2B S1480E.
Disruption of an endocytic motif (YEKL) near the C terminus of GluN2B that binds to the clathrin adaptor protein complex AP-2 also restores the surface expression of GluN2B that lacks PDZ binding (Prybylowski et al., 2005; Sanz-Clemente et al., 2010) Thus, to determine if the surface expression rescue seen with the GluN2B DD-KK S1480E mutant ( Figure 2 ) is due to decreased AP-2 binding, we used a yeast two-hybrid binding assay to examine the interaction of GluN2B with m2, the medium chain of AP-2 that binds to the GluN2B YEKL motif (Lavezzari et al., 2003) . However, the DD-KK mutations had no effect on GluN2B binding to m2 ( Figure S2) , showing that the rescue of the surface expression of GluN2B S1480E is not mediated by the disruption of AP-2 binding.
To physiologically assess the effects of GluN2B mutations on the synaptic localization of NMDARs, we developed a genetic molecular replacement strategy in organotypic hippocampal slice cultures prepared from mice with conditional knockout alleles for both GluN2A and GluN2B (Grin2a fl/fl Grin2b fl/fl ) (Granger et al., 2011) . We have previously shown that neonatal injection of a Cre-expressing virus into the hippocampus of Grin2a fl/fl Grin2b fl/fl mice completely eliminates synaptic NMDAR responses in CA1 pyramidal neurons by postnatal day 14, suggesting that GluN2A and GluN2B account for all synaptic NMDARs in these cells . Here, hippocampal slice cultures prepared from the Grin2a fl/fl Grin2b fl/fl mice were biolistically transfected with Cre at DIV2-4, and paired wholecell recordings were obtained from a Cre-expressing and a neighboring control cell at DIV18-24 ( Figure 3A ). Simultaneous paired dual-cell recordings allow for a rigorous, quantitative study of the postsynaptic effects of the genetic manipulation while controlling for presynaptic inputs. As shown in Figure 3B , 2 weeks of Cre expression reduced the NMDAR-mediated excitatory postsynaptic current (EPSC) by approximately 90% of control cell levels. Longer incubation prior to recording would likely reduce the EPSC further, though slice health becomes limiting. Importantly, the duration of NMDAR-EPSC decays (t W ) of the small remaining currents were not different from control ( Figure 3B ), suggesting that this small population of NMDARs is similar in composition to control cells. When Cre was coexpressed with a wild-type GluN2B construct, there was nearly complete recovery (90%) of the NMDAR-EPSC, with the expected lengthening of the decay kinetics from an introduced population of purely GluN2B-containing NMDARs ( Figures 3C  and 3D ).
To examine the role of the PDZ-independent interaction of GluN2B with SAP102 in the synaptic localization of NMDARs, we coexpressed Cre with the GluN2B DD-KK mutant. Consistent with the surface expression studies in dispersed neuronal cultures, the DD-KK mutant had synaptic NMDAR currents similar to wild-type, whereas GluN2B S1480E did not increase synaptic current over Cre alone ( Figures 3C and 3D) , suggesting a complete exclusion of GluN2B S1480E from synapses. Remarkably, adding the DD-KK mutation to the S1480E mutant completely rescued the synaptic localization of NMDARs ( Figures 3C and 3D ). Taken together, these results show that the secondary, PDZ-independent, SAP102 binding site on GluN2B precisely regulates the synaptic localization of NMDARs.
We next investigated if SAP102 knockdown can also rescue the surface expression defect of GluN2B S1480E. We generated a small hairpin RNA (shRNA) that efficiently reduced expression of SAP102 in dissociated cortical neurons ( Figure S3 ) and transduced neurons with lentivirus expressing the SAP102 shRNA at DIV5 and expressed FLAG-GluN2B (WT or S1480E) at DIV10. We again observed reduced surface expression for the GluN2B S1480E mutant ( Figure 4A) . Notably, however, surface expression of GluN2B S1480E was markedly increased upon SAP102 knockdown, whereas there was no significant change in GluN2B WT surface expression ( Figure 4A ). Using an shRNA against mouse SAP102 ( Figure S3 ), we knocked down SAP102 in the mouse hippocampal slice culture system. Coexpressing mouse SAP102 shRNA with the GluN2B S1480E mutant rescued approximately 50% of the synaptic NMDAR-EPSC ( Figures 4B  and 4C ). This rescue was completely reversed by coexpression of an shRNA-proofed full-length SAP102, but not a SAP102 splice variant lacking the I1 cassette in the N-terminal domain ( Figures 4B and 4C) . Importantly, knockdown of PSD-95 did not rescue the synaptic expression of GluN2B S1480E ( Figures 4B, 4C , and S3). Taken together, these results convincingly demonstrate a critical role for the PDZ-independent SAP102 binding site on GluN2B in the synaptic removal of PDZ binding-deficient GluN2B.
DISCUSSION
In this study, we have revealed a mechanism for the subunitspecific regulation of NMDARs. First, we identify two critical residues in the C terminus of GluN2B (DD-KK mutation) responsible for the GluN2B interaction with the SAP102 N terminus. Second, we show that mutation of these two critical residues rescues the surface expression defect of PDZ binding-deficient GluN2B. Third, we find that knocking down SAP102 also rescues the surface expression defect of PDZ binding-deficient GluN2B, providing powerful evidence that the DD-KK mutation on the GluN2B C termini regulates surface expression via specific binding to SAP102. Thus, the PDZ-independent interaction between GluN2B and SAP102 plays an important role in the trafficking and synaptic localization of the GluN2B-containing NMDARs. These findings support a model in which SAP102 acts as an adaptor to regulate the lateral movement of GluN2B-containing NMDARs from the synaptic to extrasynaptic membrane ( Figure 4D ).
During development, the subunit composition of synaptic NMDARs changes from mainly GluN2B-containing receptors to primarily GluN2A-containing receptors. This subunit switch is activity-dependent and underlies changes in the functional properties of NMDARs including acceleration of the kinetics of NMDAR-mediated EPSCs and increases in the channel open probabilities (Barria and Malinow, 2002; Bellone and Nicoll, 2007; Gray et al., 2011; Philpot et al., 2001; Sanz-Clemente et al., 2010) . In addition, NMDARs are rapidly exchanged between synaptic and extrasynaptic sites through lateral diffusion in immature neurons (Tovar and Westbrook, 2002) . It is clear that the subunit composition of synaptic NMDARs can undergo rapid and bidirectional switching depending on the pattern of NMDAR activation at neonatal synapses (Bellone and Nicoll, 2007; Matta et al., 2011) . However, the molecular mechanisms underlying the differential NMDAR trafficking during development and synaptic plasticity are unclear. It is clear that both phosphorylation, and protein-protein interactions regulate subunit-specific NMDAR trafficking (Chen and Roche, 2007) . In this study, we have uncovered a specific mechanism, which regulates the trafficking and synaptic targeting of GluN2B-containing NMDARs.
PSD-MAGUKs act as scaffolding proteins at the postsynaptic density and organize various signal transduction cascades. Each family member has unique properties, but they can functionally compensate for each other (Elias and Nicoll, 2007) . The expression of PSD-MAGUKs is differentially regulated during development. For example, SAP102 is expressed early and is dominant for trafficking and anchoring NMDARs at immature synapses Washbourne et al., 2004) , whereas PSD-95 is expressed later and is involved in maturation and stabilization selection medium. Results shown are 10-fold serial dilutions of yeast cells. (2) HEK293 cells were transfected with GluN1, SAP102, and GluN2B constructs. Receptors were immunoprecipitated from cell lysates with anti-GluN1 antibodies or IgG antibodies as a negative control. Immunoprecipitates were immunoblotted with anti-SAP102 or anti-GluN2B antibodies. Input = 5% of total cell lysate. The data were quantified by measuring Co-IP/input SAP102 band intensity ratios using ImageJ software. Data represent means ± SEM (n = 3 independent experiments; *p < 0.01). See also Figure S1 . of excitatory synapses (El-Husseini et al., 2000) . Although the synaptic function of PSD-95 has been extensively studied, there are relatively few studies on SAP102. Mutations in the human gene encoding SAP102 have been reported to cause mental retardation (Tarpey et al., 2004; Zanni et al., 2010) , indicating that SAP102 plays a crucial role in synaptic function. Indeed, mice lacking SAP102 display specific impairments in synaptic plasticity and show cognitive deficits (Cuthbert et al., 2007) . However, how SAP102 regulates synaptic function remains elusive. Using fluorescence recovery after photobleaching (FRAP), studies have shown that the majority of SAP102 is highly mobile in dendritic spines and the mobility is rapidly regulated by synaptic activity (Zheng et al., 2010) . In contrast, only about a third of PSD-95 is mobile and the mobility is not affected by synaptic activity. Interestingly, studies using single molecule/ particle approaches have provided evidence that surface GluN2A-containing NMDARs are much less mobile compared to surface GluN2B-containing receptors . These results are consistent with earlier studies showing preferential binding between GluN2B and SAP102 (Sans et al., 2000) . We have shown that the SAP102 N terminus contains an NMDAR binding site specific for GluN2B . We now have been able to disrupt this non-PDZ binding by mutating two critical residues in the GluN2B C terminus (DD-KK), although it remains unclear if these residues represent a direct binding site or if the mutations result in disruptive conformational changes. Furthermore, we demonstrate that the specific interaction between GluN2B and SAP102 is important for trafficking of GluN2B-containing NMDARs out of the synapse. Based on our findings, it is likely that the high surface mobility of GluN2B is due to the preferential binding to SAP102, which is extremely mobile in spines.
Glutamate receptor trafficking plays a major role in controlling the number and type of functional receptors during synaptic plasticity. Although endocytosis and exocytosis play a critical role in trafficking of glutamate receptors and synaptic plasticity, lateral diffusion is also important Kennedy and Ehlers, 2006) . Endocytic proteins, such as clathrin, AP-2 and dynamin, are localized lateral to the PSD, forming ''endocytic zones,'' allowing efficient endocytosis of receptors that diffuse away from synapses (Rá cz et al., 2004) . Therefore, it has been suggested that removal of synaptic receptors is a two-step process: uncoupling of receptors from the PSD, followed by lateral movement to an endocytic zone (Rá cz et al., 2004) . Our studies identify a function of SAP102 in regulating internalization of GluN2B-containing receptors. Our model is consistent with the two-step process of internalization ( Figure 4D ). First, phosphorylation of GluN2B on S1480 within the PDZ ligand by CK2 disrupts the interaction between synaptic NMDARs and synaptic MAGUKs, such as PSD-95. Second, GluN2B bound to SAP102 through the non-PDZ binding is laterally diffused to the endocytic zone. Extrasynaptic GluN2B is dephosphorylated on Y1472, associates with the AP-2-clathrin endocytic complex, and undergoes endocytosis. Our findings on the subunit-specific interactions between GluN2B and SAP102 provide insight into MAGUKspecific roles in regulating synaptic NMDARs, which were previously unappreciated. 
DD-KK Mutations Rescue the Surface Expression of GluN2B S1480E in Neurons
Hippocampal neurons were transfected with GluN2B constructs containing an extracellular GFP tag. Surface staining was performed with anti-GFP and Alexa 568-conjugated (red) anti-rabbit secondary antibodies, followed by fixation and permeabilization, and the internal pool of receptors was labeled with anti-GFP and Alexa 488-conjugated (green) anti-rabbit secondary antibodies. Data represent means ± SEM (n = 27; *p < 0.01) (n = 3 independent experiments). See also Figure S2 . Data were analyzed by the Mann-Whitney U test, *p < 0.0001 compared with GluN2B-S1480E. Actual values for all data can be found in Table S1 .
Figure 4. SAP102 Controls GluN2B Synaptic Expression
(A) SAP102 was knocked down in hippocampal cultures by the lentiviral induction of a specific shRNA at DIV5 and Flag-tagged GluN2B constructs (WT or S1480E) were transfected at DIV10. Surface staining was performed with anti-Flag and Alexa 568 secondary antibodies (red) and, after permeabilization, the intracellular pool was labeled with anti-Flag and Alexa 663 secondary antibodies (green). n for GluN2B WT (+/À shRNA) = 26, 26; n for S1480E (+/À shRNA) = 35, 32 (n = 4 independent experiments). Data represent means ± SEM. *p < 0.001. See also Figure S3 . ( 
EXPERIMENTAL PROCEDURES
The use and care of animals used in this study followed the guidelines of the GHSU, UCSF, and NIH Animal Research Advisory Committees. Yeast twohybrid assays were performed using L40 yeast strain cotransformed with pBHA and pGAD10 constructs. Immunoprecipitation (IP) was performed at 24 hr after transfection with indicated antibodies. Immunocytochemistry assays were performed in 14 DIV dissociated hippocampal cultures 2 days after transfection with GluN2B constructs. Hippocampi were dissected from P7 Grin2a fl/fl Grin2b fl/fl mice and cotransfected after 2-4 days in culture with pFUGW-Cre:mCherry and either pCAG-GFP or pCAG-GluN2B-IRES-GFP or mutants. Slices were cultured for an additional 14-20 days and dual whole-cell patch-clamp recordings were performed from neighboring CA1 pyramidal cells. NMDAR-EPSCs were recorded at +40 mV in the presence of 10 mM NBQX. Further details available in the Extended Experimental Procedures. 
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DNA Constructs
The pBHA-GluN2B (amino acids 1315 -1441), pBHA-GluN2B (amino acids 1315 -1400), pBHA-GluN2B (amino acids 1315 -1353) constructs, were generated by introducing a stop codon at amino acid 1442, 1401 and 1354 in pBHA-GluN2B (amino acids 1315 -1475) respectively using site-directed mutagenesis. GluN2B (amino acids 1422 -1441), GluN2B (amino acids 1400 -1441), GluN2B (amino acids 1353 -1400) and GluN2B (amino acids 1353 -1441) were amplified by PCR using synthetic primers that include flanking EcoRI recognition sequences and subcloned into the LexA fusion vector pBHA. The GluN2B (amino acids 1315 -1420) -GluN2A (amino acids 1400 -1464) chimera and the GluN2A (amino acids 1304 -1400) -GluN2B (amino acids 1422 -1482) chimera were amplified by PCR using synthetic primers and subcloned into the LexA fusion vector pBHA. GluN2B containing the D1378K, D1391K, or D1392K mutations was generated by site-directed mutagenesis. GFP-GluN2B (amino acids 1 -1441), GFP-GluN2B (amino acids 1 -1400) and GFP-GluN2B (amino acids 1 -1353) were generated by mutating K1442, S1401 and S1354 to a stop codon, respectively using site-directed mutagenesis. shRNA oligonucleotides were inserted into the FHUGW vector. The following shRNA targeting sequences were used for rat SAP102: CCAAGTCCATCGAAGCACT; mouse SAP102: CCAAGTCCATTGAAGCACT, and PSD-95 (identical in mouse and rat): TCACGATCATCGCTCAGTATA (Elias et al., 2006) . The shRNA-proofed SAP102 constructs used in mouse hippocampal slice culture are rat clones .
Yeast Two-Hybrid Assay
The yeast two-hybrid assay was performed as described previously (Chen et al., 2006) . Briefly, constructs in the LexA-fusion vector pBHA (TRP1 plasmid) and the Gal4 activation domain-fusion vector pGAD10 (LEU2 plasmid) were cotransformed into L40 yeast. After transformation, the yeast were plated in synthetic complete medium lacking leucine and tryptophan (+His). Three independent yeast colonies were selected and assayed for expression of the reporter HIS3 gene in synthetic complete medium lacking leucine, tryptophan and histidine (ÀHis), demonstrating protein-protein interactions. 3-Aminotriazole (3-AT) (10 mM) was included in the ÀHis medium to reduce or eliminate the background transactivation. All plates were photographed after 3 days of incubation at 30 C.
Immunoprecipitation Immunoprecipitation was performed as described previously (Cousins and Stephenson, 2012) with some modifications. Briefly, HEK293 cells were transiently transfected with GluN1, GFP-GluN2B and SAP102 using the calcium phosphate method. Cells were harvested 24 hr post-transfection. Transfected HEK293 cells were rinsed twice with PBS and then solubilized for 1 hr at 4 C with 50 mM Tris-citrate, pH 7.4, 240 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% Triton X-100, protease inhibitor mixture (Roche Applied Science) and phosphatase inhibitor cocktail 1 and 2 (Sigma). The supernatant was collected and centrifuged at 100,000 x g for 20 min at 4 C. For immunoprecipitation, 2 mg of IgG or anti-NR2B antibody (NeuroMab) was used. The supernatant was incubated with antibodies overnight at 4 C. Protein G Dynabeads (Invitrogen) were added, and samples were incubated for 30 min at room temperature and washed three times with solubilization buffer. Precipitates were resolved by SDS-PAGE and transferred to PVDF membrane. The membrane was analyzed by immunoblotting with the relevant antibodies as indicated.
Neuronal Cultures and Immunocytochemistry
Primary hippocampal cultures were prepared from E17-19 Sprague-Dawley rats. Dissociated neurons were plated on poly-D-Lysinecoated coverslips in Neurobasal medium supplemented with B27 and L-glutamine. Hippocampal neurons were transfected at 10-12 days in vitro (DIV) using lipofectamine (lipofectamine 2000, Invitrogen) and immunocytochemistry were performed at DIV14. Briefly, transfected neurons were incubated with polyclonal anti-GFP antibody (Invitrogen) or anti-FLAG antibody (Sigma) for 15 min at room temperature to label surface-expressed protein. The cells were fixed in 4% PFA for 15 min and incubated with Alexa 568-conjugated (red) anti-rabbit secondary antibody (molecular Probes) for 30 min. The cells were permeabilized with 0.25% TX-100, incubated with 10% normal goat serum, and labeled with anti-GFP antibody (Invitrogen) or anti-FLAG antibody (Sigma) for 30 min at room temperature. Following extensive washing, cells were incubated with Alexa 488-conjugated (green; anti-GFP) or Alexa 633-conjugated (green; anti-FLAG) anti-rabbit secondary antibody for 30 min, and mounted with a ProLong Gold Antifade kit (Molecular Probes). Images were collected with a 63X objective on a Zeiss LSM 700 confocal microscope. Series of optical sections collected at intervals of 0.5 mm were used to create maximum projection images. For quantitative analysis, images from three dendrites per neuron from at least three neurons per experiment were collected and quantitated using ImageJ software. At least three independent experiments were performed per condition, and the number of neurons (n) for each condition is indicated in the corresponding figure legend. Measurements were analyzed in Microsoft Excel, and statistical significance was determined by Student's t test.
Electrophysiology in Organotypic Slice Cultures Double-floxed GluN2AGluN2B (Grin2a fl/fl Grin2b fl/fl ) mice were generated as previously described (Akashi et al., 2009; Gray et al., 2011; Mishina and Sakimura, 2007) , and were housed according to the IACUC guidelines at the University of California, San Francisco. Cultured slices were prepared and transfected as previously described (Schnell et al., 2002) . Briefly, hippocampi were dissected from P7 Grin2a fl/fl Grin2b fl/fl mice and biolistically cotransfected after 2-4 days in culture with pFUGW-Cre:mCherry (expressing a nuclear-targeted Cre:mCherry fusion protein) and either pCAGGS-GFP or pCAGGS-GluN2B-IRES-GFP (with wild-type or mutant mouse GluN2B). Slices were cultured for an additional 14-20 days before recording. Slices were recorded in a submersion chamber on an upright Olympus microscope, perfused in room temperature normal ACSF saturated with 95% O2/5% CO2. Picrotoxin (0.1 mM) and NBQX (10 mM) were added to the ACSF to block GABA A and AMPA receptors respectively. CA1 pyramidal cells were visualized by infrared differential interference contrast microscopy and transfected neurons were identified by epifluorescence microscopy. The intracellular solution contained (in mM) CsMeSO4 135, NaCl 8, HEPES 10, Na-GTP 0.3, Mg-ATP 4, EGTA 0.3, and QX-314 5. Cells were recorded with 3 to 5MU borosilicate glass pipettes, following stimulation of Schaffer collaterals with bipolar placed in stratum radiatum of the CA1 region. Series resistance was monitored and not compensated, and cells in which series resistance varied by 25% during a recording session were discarded. Synaptic responses were collected with a Multiclamp 700B amplifier (Axon Instruments, Foster City, CA), filtered at 2 kHz and digitized at 10 Hz. All paired recordings involved simultaneous whole-cell patch-clamp recordings from a transfected and neighboring untransfected neuron. EPSCs were elicited by stimulation of Schaffer collaterals with AMPAR-EPSCs recorded at À70mV and NMDAR-EPSCs recorded at +40 mV in the presence of 10 mM NBQX. The stimulus was adjusted to evoke a measurable, monosynaptic EPSC in both cells. Paired amplitude data were analyzed with a Wilcoxon signed-rank test and the paired decay kinetics were analyzed with a two-tailed paired Student's t test. Comparison of paired data groups were performed using a Mann-Whitney U test. Linear regressions were obtained using the least-squares method. All error bars represent standard error measurement.
